Vigil Neuroscience, Inc.

Contributing Author

Recent Articles by Vigil Neuroscience, Inc.

Jun-04	Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP VIGL GlobeNewswire
May-21	Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi VIGL GlobeNewswire
May-07	Vigil Neuroscience Reports First Quarter 2025 Financial Results and Provides Recent Business Updates VIGL GlobeNewswire